MRI

MRI prior to commencing bevacizumab

Axial T1 C+
Modality: MRI (T1 C+)

- “ In response to the anti-angiogenic chemotherapy (bevacizumab), the post-treatment MRI shows significant reduction in enhacement, mass affect and t...”

View full size version of Pseudoresponse to bevacizumab in high grade glioma

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.